This is a structured, data-backed health support system built around three principles:
Honest interpretation of objective data (Nov 2025 baseline → May 2026 Round 2 results) rather than hopeful inference.
Calibrated language — separating what's confirmed from what's hypothesis, with explicit uncertainty markers.
Doctor-first protocol — every recommendation requires physician second-opinion before action. This is a preparation document, not a clinical plan.
The system has been iterated five times: initial Sonnet analysis → self-audit after prescription verification → Codex adversarial review (22 corrections) → Codex follow-up verification (9 additional corrections) → Round 2 lab data integration (20 May 2026).
Round 2 headline (19-20 May 2026)
Partial report received. 5 markers normalized since Nov 2025: B12, TSH, CRP, Calcium, FBS, Uric Acid. HDL improved. Vitamin D loading worked. Stool clean (no parasites). One new safety concern: Potassium dropped to 3.62 — close to lower limit, amplifies QT risk while on Nortriptyline + Domperidone. 5 critical results still pending (Magnesium, Anti-CCP, HOMA-IR, PTH, Anti-TPO/Anti-Tg) between 21-24 May.
What this system is NOT
It is not a clinical recommendation, treatment plan, or replacement for medical advice. It is a structured way to prepare for doctor visits and track trends over time.
Current Status Dashboard
As of 20 May 2026 — what's active, pending, and resolved
Top Safety Finding
Potassium 3.62
Close to lower limit; amplifies QT risk with current meds
Tests Pending
5 results by 24 May
Anti-TPO, Anti-CCP, HOMA-IR, PTH, Magnesium
Safety Watch
QT + Liver
QT drugs + low K+; AST mildly up at 36
Resolved (5 markers)
B12, TSH, CRP, Ca, FBS
All moved into normal range since Nov 2025
Improving
HDL 34→40
Still below 50 target but +6 mg/dL gain
Trending Wrong
Lipids drifting
TG 124→168 (borderline-high); possible Pregabalin weight effect
System Iteration Timeline
15 November 2025Comprehensive Platinum Full Body Checkup — Tata 1mg, Ranchi. Source of all baseline data.
18 April 2026Doctor visit — 1st CMC OA bilateral, multiple toe pain, left thigh pain 80% of complaint. X-rays ordered. 10-day medication course prescribed.
28 April 2026Initial system built — Lab analysis, doctor visit notes, supplement plan, preventive plan, test panel.
29 April 2026Codex adversarial review — 22 corrections applied (Hashimoto's overclaim softened, K2-GOOD risk flagged, drug names verified, etc.).
1 May 2026Active symptom: severe constipation — Drug-induced, intervention plan created. Status post-update: pending confirmation.
19 May 2026Round 2 blood draw — Tata 1mg, Ranchi. Lab Visit ID RNC25709. Sample collection 06:15 AM.
20 May 2026Partial report received + trajectory analysis — 15 of 20+ tests reported. Major wins on B12, TSH, CRP, Calcium, FBS. New concern: Potassium 3.62. Stool clean. 5 critical tests pending between 21-24 May.
21-24 May 2026 (expected)Full report completion — Magnesium + Anti-CCP (21 May), HOMA-IR (22 May), PTH (23 May), Anti-TPO + Anti-Tg (24 May). Final analysis after 24 May.
Lab Findings — Trajectory (Nov 2025 → May 2026)
All values verified against source PDFs. May 2026 = partial report; 5 results pending 21-24 May.
✅ Markers That Normalized (Major Wins)
Marker
Nov 2025
May 2026
Reference
Verdict
TSH
7.275
4.526
0.55–4.78 µIU/mL
✅ Normalized — subclinical hypothyroid resolved without thyroid medication. Antibody status (24 May) will explain.
Vitamin B12
170
361
211–911 pg/mL
✅ Resolved — Yopreg-NM methylcobalamin worked.
CRP (Quantitative)
5.30
2.30
0–3.3 mg/L
✅ Normalized — systemic inflammation resolved.
Calcium
8.3
8.9
8.7–10.4 mg/dL
✅ Normalized — Vit D loading + dietary improvement worked.
Worsening — RBC turnover from B12 correction still in progress (120-day cycle).
LDL / Total Chol
60 / 118
79 / 153
<100 / <200
Drifting up — still desirable range but trending wrong way.
⏳ Results Still Pending (21-24 May 2026)
Test
Expected
What It Answers
Magnesium
21 May
Critical for QT risk picture (low Mg amplifies same as low K+)
Anti-CCP
21 May
Rules in/out early Rheumatoid Arthritis
HOMA-IR
22 May
Insulin resistance — explains HbA1c paradox
PTH (Intact)
23 May
Parathyroid axis interpretation with calcium normalization
Anti-TPO + Anti-Thyroglobulin
24 May
Is the (now-resolved) hypothyroidism autoimmune (Hashimoto's)?
Still Within Normal — Stable
Free T3 (2.82), Free T4 (1.11), LFT majority (ALT 37, ALP 113, GGT 13, Bilirubin 0.37, Protein 7.3, Albumin 4.3, Globulin 3.0), Creatinine 0.84, BUN 20, Sodium 142, Chloride 105, hs-CRP 0.64, ESR 19, Phosphorus 5.10 (upper limit), urine clean.
Working hypothesis updatesResolved: IgE-from-parasites ruled out (stool clean). Mixed: Metabolic-pain link partly supported (B12 + TSH + CRP all corrected — pain trajectory needs Ravi's confirmation). Pending: Hashimoto's hypothesis (24 May antibody result), insulin resistance question (22 May HOMA-IR), RA ruling out (21 May Anti-CCP).
📎 Source Documents
Raw lab reports and analysis documents — for the doctor's reference. Click to open in new tab.
Note on prescription document
The original handwritten prescription scan is not yet in the system. The verified drug compositions are transcribed in the "Doctor Visit" document above. If a scan becomes available, it will be added here.
Current Medications
Verified compositions from April 2026 prescription
Composition: Calcitriol 0.25 mcg + Calcium Carbonate 625 mg (250 mg elemental) + Vitamin K2-7 22.5 mcg + Boron 500 mcg + Zinc 7.5 mg.
⚠️ Coordination required with prescriber
K2-GOOD contains Calcitriol (active Vitamin D), which combined with the Cholecalciferol loading dose creates hypercalcemia risk. Do not stop unilaterally — identify who prescribed it and why, then have both prescribers coordinate.
Safety Priorities (Updated 20 May 2026)
Items to raise with treating prescriber, in priority order
1. ⚠️ NEW: Potassium 3.62 + QT-prolonging Medications
Potassium dropped from 4.48 to 3.62 (close to lower limit 3.5). Low K+ is the #1 amplifier of QT prolongation from Nortriptyline + Domperidone. In an elderly female on two QT-prolonging drugs, this is the combination that causes Torsades de Pointes.
Immediate actions: Confirm whether she's still on Yopreg-NM and Rowet-DSR. Increase dietary potassium (bananas, coconut water, leafy greens, dates, sweet potato). Request ECG. Magnesium result (21 May) will complete the picture. Repeat K+ in 1-2 weeks.
2. QT Prolongation Risk: Nortriptyline + Domperidone
Both drugs independently prolong QT interval. Combined risk in a 63F warrants baseline ECG and explicit prescriber awareness. Now amplified by low K+ above.
3. NEW: Mild AST Elevation (36, ref <34)
Likely Chlorzoxazone (rare hepatotoxicity) or Aceclofenac strain from 10-day course. ALT also rose 29→37. Monitor LFT in 4-6 weeks. If she's still on these drugs, flag this finding.
4. NEW: Triglycerides Borderline-High (168, ref <150)
Up from 124. The Pregabalin weight gain risk we predicted may be materializing. Track her weight; if up, raise with prescriber about alternative nerve pain agents (Duloxetine, Gabapentin).
5. Fall Risk Stack: Pregabalin + Nortriptyline + Chlorzoxazone
Three CNS-active drugs simultaneously + active sciatica = high cumulative fall risk. Home modifications: lighting, grab bars, no loose rugs, slow position changes, supervised exercise. Confirm she's still on this stack or it's tapered.
6. K2-GOOD Hypercalcemia Risk
Calcitriol (active D3) + Cholecalciferol loading + Calcium Carbonate could cause hypercalcemia. Calcium has normalized at 8.9 — within range. Still: coordinate with prescriber. PTH result (23 May) will provide more context.
7. Anticholinergic Burden (Nortriptyline)
Tricyclics in elderly cause dry mouth, constipation, urinary retention, blurred vision, sedation, orthostatic hypotension, possible cognitive slowing. American Geriatrics Society Beers Criteria flag TCAs as potentially inappropriate in elderly — high-vigilance category.
Test Panel — Round 2 Status
Drawn 19 May 2026 · 15+ results in, 5 pending 21-24 May
Not in partial report; not on pending list — possible silent skip; verify with lab
Imaging / Other Tests — Status
Investigation
Status
Reason
ECG (12-lead)
More urgent now
QT risk now compounded by low K+ 3.62 — schedule before next dose round
DEXA Scan
Still pending
Bone density baseline; book separately
Comprehensive Eye Exam
Pending
Glaucoma + general assessment
MRI L-S Spine
If pain persists
Disc/nerve compression detail; ask Ravi about current pain
Supplement Framework — Updated After Round 2
Most Tier 1 supplements now on HOLD because the deficiencies they targeted have resolved on doctor's regimen alone.
Major update: Most supplements deferred indefinitely
The doctor's medication course + Vitamin D loading has resolved most of the deficiencies that justified the supplement plan. B12, Calcium, and Vitamin D are now within range. CRP normalized. Adding supplements on top would be redundant or potentially harmful. New emphasis: dietary potassium and dietary magnesium until pending labs confirm next steps.
Tier 1 — Most HOLD'd Post-Round 2
Supplement
Dose
Status (Updated 20 May)
Methylcobalamin (B12)
—
REMOVED — B12 normalized at 361; Yopreg-NM worked. Recheck at 3 months post-course.
Vitamin D3 + K2 (MK-7)
—
HOLD — Vit D 42.9 sufficient; loading dose worked. Don't stack more on top.
Calcium Citrate
—
HOLD — Calcium normalized at 8.9; dietary maintenance is enough.
Magnesium Glycinate
200 mg start
PENDING 21 May result — but increase dietary Mg now (pumpkin seeds, almonds, dark leafy greens, dark chocolate).
Dietary Potassium (NEW)
—
START NOW — bananas, coconut water, leafy greens, dates, sweet potato. K+ 3.62 + QT-prolonging drugs is the priority concern.
Tier 2 — Conditional on Pain Status
Supplement
Status
Decision Logic
Boswellia Serrata + Curcumin
CONDITIONAL
If pain is still significant after meds taper → reasonable to add. If pain is improving and CRP normalized → defer.
Omega-3 (EPA+DHA) 2g daily
CONDITIONAL
HDL is improving slowly (40 now); could accelerate. Wait until confirmed off Aceclofenac to avoid antiplatelet stack.
Tier 4 — Conditional on Pending Results
Selenium 150-200 mcg: HOLD until Anti-TPO result on 24 May. If positive (Hashimoto's confirmed), selenium is well-supported. If negative, minimal thyroid benefit.
Zinc 15 mg: General immune cofactor; reasonable but low priority.
Preventive Health Plan
Six pillars integrated with daily/weekly/quarterly rhythm
1. Movement
30 min walking daily
Resistance training 2×/week (light)
Tai Chi or gentle yoga 3-4×/week
Clinical Pilates 1-2×/week (after X-ray)
Avoid spinal loading until X-ray clears
2. Nutrition
Protein: 1.0-1.2 g/kg body weight
Vegetables 2 fistfuls cooked + 1 raw
Millets > white rice (bajra, jowar, ragi)
Calcium-rich daily (sesame, ragi, dairy)
5-min walk after every meal (powerful blood sugar effect)
3. Sleep
Fixed wake time daily
7-8 hour window
No screens 30-45 min before bed
Bedroom cool, dark, quiet
Nortriptyline at HS (bedtime) as prescribed
4. Nervous System
Slow nasal breathing (6/min) — 5 min ×2 daily
Bhramari pranayama — 5 min evening
Anulom Vilom — 5 min morning
Mindfulness 10 min daily
Weekly: yoga nidra or satsang
5. Connection
Daily meaningful conversation
30 min cognitive engagement
Weekly social event
Monthly outing
Daily check-in protocol (gap identified)
6. Monitoring
Monthly: BP, weight, pain log
3-monthly: HbA1c, TSH, B12
6-monthly: Vit D, Ca, lipids, LFT, KFT
Annual: ECG, mammography, Lp(a)
2-yearly: DEXA
The single most important sentence in the plan
If she does only three things consistently: (1) Walk 30 minutes outdoors every morning. (2) Eat protein + vegetables + small starch at each meal, with a 5-minute walk after. (3) Sleep 7-8 hours at consistent times. These three handle ~70% of the metabolic, musculoskeletal, and inflammatory risk.
Active Symptom Tracker
Symptoms under active management — status pending confirmation from Ravi
Status: Awaiting confirmation
Constipation was reported severe on 1 May 2026. Intervention plan was created. Current status (20 May) needs confirmation from Ravi — is it resolved, improving, or still active? This dramatically changes management.
Severe Constipation (1 May 2026 onset)
🚨 Seek immediate medical attention if:
No bowel movement in 5+ days; severe abdominal pain or distention; vomiting; inability to pass gas; blood in stool; sudden confusion or weakness.
Why This Is Happening
At least 5 of her drugs cause constipation: Nortriptyline (largest driver — anticholinergic), Pregabalin, Chlorzoxazone, Rabeprazole, and possibly Calcium Carbonate in K2-GOOD. Plus reduced mobility from thigh pain and likely dehydration.
Graded Intervention
Step
Action
1. Hydration
2.5-3 L water/day, warm preferred; 1 glass warm water on rising